Uxin (NASDAQ: UXIN)'s decision to pivot to 2C sales may not be working out quite as well as the company expected. While sales were up slightly quarter-on-quarter, 2C transaction volume came in at a fraction of last year's levels.

The Chinese used ...

Join now to access
the full content.